• J A Páramo, E Ruiz de Gaona, R García, P Rodríguez, and R Lecumberri.
• Servicio de Hematología, Clínica Universitaria, Facultad de Medicina, Universidad de Navarra, España. japaramo@unav.es
• Rev Med Univ Navarra. 2007 Jan 1;51(1):13-7.

AbstractDeep-vein thrombosis (DVT) is a common condition that can lead to complications such as postphlebitic syndrome, pulmonary embolism and death. Currently, an algorithm strategy combining pretest probability, D-dimer testing and compression ultrasonography imaging allows for safe and convenient estimation of suspected lower-limb thrombosis. The mainstay of treatment is anticoagulation therapy. The use of low-molecular-weight heparin or pentasaccharide (fondaparinux) allows for outpatient management of most patients with DVT. The duration of anticoagulation depends on whether the primary event was idiopathic or secondary to a transient risk factor. Interventions such as thrombolysis and placement of inferior vena cava filter are reserved for special situations.

34 keywords...

hide…